Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review.

IF 6.2
James Jae, Yilong Li, Clara Sun, Alison Allan, John Basmaji, Stephanie Chilton, Mohammad Hmidan Simsam, Raymond Kao, Adrian Owen, Neil Parry, Fran Priestap, Bram Rochwerg, Shane Smith, Alexis F Turgeon, Kelly Vogt, Eric Walser, Alla Iansavitchene, Ian Ball
{"title":"Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review.","authors":"James Jae, Yilong Li, Clara Sun, Alison Allan, John Basmaji, Stephanie Chilton, Mohammad Hmidan Simsam, Raymond Kao, Adrian Owen, Neil Parry, Fran Priestap, Bram Rochwerg, Shane Smith, Alexis F Turgeon, Kelly Vogt, Eric Walser, Alla Iansavitchene, Ian Ball","doi":"10.1007/s11481-024-10121-1","DOIUrl":null,"url":null,"abstract":"<p><p>Traumatic brain injury (TBI) is a leading cause of mortality and morbidity amongst trauma patients. Its treatment is focused on minimizing progression to secondary injury. Administration of propranolol for TBI maydecrease mortality and improve functional outcomes. However, it is our sense that its use has not been universally adopted due to low certainty evidence. The literature was reviewed to explore the mechanism of propranolol as a therapeutic intervention in TBI to guide future clinical investigations. Medline, Embase, and Scopus were searched for studies that investigated the effect of propranolol on TBI in animal models from inception until June 6, 2023. All routes of administration for propranolol were included and the following outcomes were evaluated: cognitive functions, physiological and immunological responses. Screening and data extraction were done independently and in duplicate. The risk of bias for each individual study was assessed using the SYCLE's risk of bias tool for animal studies. Three hundred twenty-three citations were identified and 14 studies met our eligibility criteria. The data suggests that propranolol may improve post-TBI cognitive and motor function by increasing cerebral perfusion, reducing neural injury, cell death, leukocyte mobilization and p-tau accumulation in animal models. Propranolol may also attenuate TBI-induced immunodeficiency and provide cardioprotective effects by mitigating damage to the myocardium caused by oxidative stress. This systematic review demonstrates that propranolol may be therapeutic in TBI by improving cognitive and motor function while regulating T lymphocyte response and levels of myocardial reactive oxygen species. Oral or intravenous injection of propranolol following TBI is associated with improved cerebral perfusion, reduced neuroinflammation, reduced immunodeficiency, and cardio-neuroprotection in preclinical studies.</p>","PeriodicalId":73858,"journal":{"name":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","volume":"19 1","pages":"33"},"PeriodicalIF":6.2000,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11481-024-10121-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity amongst trauma patients. Its treatment is focused on minimizing progression to secondary injury. Administration of propranolol for TBI maydecrease mortality and improve functional outcomes. However, it is our sense that its use has not been universally adopted due to low certainty evidence. The literature was reviewed to explore the mechanism of propranolol as a therapeutic intervention in TBI to guide future clinical investigations. Medline, Embase, and Scopus were searched for studies that investigated the effect of propranolol on TBI in animal models from inception until June 6, 2023. All routes of administration for propranolol were included and the following outcomes were evaluated: cognitive functions, physiological and immunological responses. Screening and data extraction were done independently and in duplicate. The risk of bias for each individual study was assessed using the SYCLE's risk of bias tool for animal studies. Three hundred twenty-three citations were identified and 14 studies met our eligibility criteria. The data suggests that propranolol may improve post-TBI cognitive and motor function by increasing cerebral perfusion, reducing neural injury, cell death, leukocyte mobilization and p-tau accumulation in animal models. Propranolol may also attenuate TBI-induced immunodeficiency and provide cardioprotective effects by mitigating damage to the myocardium caused by oxidative stress. This systematic review demonstrates that propranolol may be therapeutic in TBI by improving cognitive and motor function while regulating T lymphocyte response and levels of myocardial reactive oxygen species. Oral or intravenous injection of propranolol following TBI is associated with improved cerebral perfusion, reduced neuroinflammation, reduced immunodeficiency, and cardio-neuroprotection in preclinical studies.

Abstract Image

普萘洛尔对创伤性脑损伤的保护作用机制的临床前研究:系统回顾。
创伤性脑损伤(TBI)是导致创伤患者死亡和发病的主要原因。治疗的重点是尽量减少继发性损伤的发展。使用普萘洛尔治疗创伤性脑损伤可降低死亡率并改善功能预后。然而,我们认为,由于证据的确定性较低,普萘洛尔的使用尚未得到普遍采用。我们回顾了相关文献,以探索普萘洛尔作为创伤性脑损伤治疗干预措施的机制,从而为未来的临床研究提供指导。研究人员检索了 Medline、Embase 和 Scopus 中从开始到 2023 年 6 月 6 日调查普萘洛尔对动物模型中创伤性脑损伤影响的研究。研究纳入了普萘洛尔的所有给药途径,并对以下结果进行了评估:认知功能、生理和免疫反应。筛选和数据提取均独立完成,一式两份。每项研究的偏倚风险均采用 SYCLE 的动物研究偏倚风险工具进行评估。共发现 323 篇引文,14 项研究符合我们的资格标准。数据表明,普萘洛尔可在动物模型中通过增加脑灌注、减少神经损伤、细胞死亡、白细胞动员和 p-tau 积累来改善创伤后认知和运动功能。普萘洛尔还可减轻创伤性脑损伤诱发的免疫缺陷,并通过减轻氧化应激对心肌造成的损伤而起到保护心脏的作用。本系统综述表明,普萘洛尔可改善认知和运动功能,同时调节 T 淋巴细胞反应和心肌活性氧水平,从而治疗创伤性脑损伤。在临床前研究中,创伤性脑损伤后口服或静脉注射普萘洛尔与改善脑灌注、减少神经炎症、减少免疫缺陷和心脏神经保护有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信